283 related articles for article (PubMed ID: 31564474)
1. Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
Huang C; Zhu HX; Yao Y; Bian ZH; Zheng YJ; Li L; Moutsopoulos HM; Gershwin ME; Lian ZX
J Autoimmun; 2019 Nov; 104():102333. PubMed ID: 31564474
[TBL] [Abstract][Full Text] [Related]
2. An overview of immune checkpoint therapy in autoimmune diseases.
Mohammadi P; Hesari M; Chalabi M; Salari F; Khademi F
Int Immunopharmacol; 2022 Jun; 107():108647. PubMed ID: 35228033
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
Ceeraz S; Nowak EC; Burns CM; Noelle RJ
Arthritis Res Ther; 2014; 16(5):469. PubMed ID: 25606596
[TBL] [Abstract][Full Text] [Related]
4. SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Liang Y; Xu WD; Peng H; Pan HF; Ye DQ
Eur J Immunol; 2014 May; 44(5):1265-75. PubMed ID: 24595859
[TBL] [Abstract][Full Text] [Related]
5. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
Zhang Q; Vignali DA
Immunity; 2016 May; 44(5):1034-51. PubMed ID: 27192568
[TBL] [Abstract][Full Text] [Related]
6. Roles of A20 in autoimmune diseases.
Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
[TBL] [Abstract][Full Text] [Related]
7. Targeting IL-10 in auto-immune diseases.
Tian G; Li JL; Wang DG; Zhou D
Cell Biochem Biophys; 2014 Sep; 70(1):37-49. PubMed ID: 24639111
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13: A promising therapeutic target for autoimmune disease.
Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in the pathogenesis of autoimmune diseases.
Chen JQ; Papp G; Szodoray P; Zeher M
Autoimmun Rev; 2016 Dec; 15(12):1171-1180. PubMed ID: 27639156
[TBL] [Abstract][Full Text] [Related]
10. The CD27-CD70 pathway and pathogenesis of autoimmune disease.
Han BK; Olsen NJ; Bottaro A
Semin Arthritis Rheum; 2016 Feb; 45(4):496-501. PubMed ID: 26359318
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
12. Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system.
Fülöp T; Larbi A; Dupuis G; Pawelec G
Arthritis Res Ther; 2003; 5(6):290-302. PubMed ID: 14680505
[TBL] [Abstract][Full Text] [Related]
13. NLRP3: A promising therapeutic target for autoimmune diseases.
Shen HH; Yang YX; Meng X; Luo XY; Li XM; Shuai ZW; Ye DQ; Pan HF
Autoimmun Rev; 2018 Jul; 17(7):694-702. PubMed ID: 29729449
[TBL] [Abstract][Full Text] [Related]
14. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
Liu W; Zang X
Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
[TBL] [Abstract][Full Text] [Related]
15. Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
Calabrese LH; Caporali R; Blank CU; Kirk AD
J Autoimmun; 2020 Dec; 115():102546. PubMed ID: 32980229
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
17. The AKT axis as a therapeutic target in autoimmune diseases.
Wu T; Mohan C
Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):145-50. PubMed ID: 19519464
[TBL] [Abstract][Full Text] [Related]
18. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
Clanchy FI; Sacre SM
Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune diseases in China.
Li R; Sun X; Liu X; Yang Y; Li Z
Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic applications of exosomes in different autoimmune diseases.
Xu H; Jia S; Xu H
Clin Immunol; 2019 Aug; 205():116-124. PubMed ID: 31228581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
